CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BNTX

RO7198457 intravenous (IV)

Phase 2
BioNTech SE (BNTX)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Nov '26
BNTXPhase 2
✗Negative

RO7198457 intravenous (IV) Phase 2 Est. Readout

RO7198457 intravenous (IV)
Nov 2026~
CT.gov
Competitive Landscape

1 competitor in Colorectal Cancer Stage II

View Full Landscape
Drug Information

Target Indication

Colorectal Cancer Stage II

Clinical Trial

NCT04486378

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.